Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 181 composition records across product categories including Furniture and furnishings, Construction and building materials, Laboratory supplies.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of DOCUSATE SODIUM in our catalog (fda_ndc).
Products
330
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 181 composition records across product categories including Furniture and furnishings, Construction and building materials, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Solubility enhancer, Emulsifier.
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.02 %w/v
US
FDA
Bora Bora Waters
Febreze
Route: ORAL; Dosage form: CAPSULE; Potency: 8.2 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 48 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 0.77 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 6 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 6 mg
US
FDA
FDA NDC lists this ingredient in 305 active drug products and 330 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.